
    
      The purpose of the RESHAPE-HF1-FU Study is to follow up the safety and effectiveness of the
      MitraClip System in the treatment of clinically significant Functional Mitral Regurgitation
      (FMR) in patients with New York Heart Association (NYHA) Functional Class III or IV chronic
      heart failure, former participants in the RESHAPE-HF Trial (Abbott Vascular).
    
  